Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biocept Inc.
DescriptionDiagnostic to detect circulating tumor cells (CTC) in the peripheral blood followed by genetic analysis of HER-2 and amplification by fluorescence in situ hybridization (FISH)
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today